Star Individuals
Band 1
Band 3
About
Provided by Eileen M McMahon
Practice Areas
Eileen is a co-founder of the intellectual property and food and drug regulatory practices at Torys. She represents the entire spectrum of companies on regulatory clearance and intellectual property protection of products. Across sectors—including life sciences (pharmaceuticals, medical devices, natural health products), agribusiness, consumer products and more—Eileen helps clients identify, protect and leverage IP and regulatory assets, obtain and maintain market exclusivity, handle high-risk situations (corrective actions, recalls, regulatory orders), and navigate the impact of current and proposed laws on clients’ ability to sell products. Eileen also has market-leading experience with patented medicines and oversight of Canada’s Patented Medicines Prices Review Board (PMPRB). Eileen also represents investors and companies looking to finance or invest in companies with intellectual property and regulatory assets, as well as companies looking to acquire or divest such assets.
Eileen’s unique experience and strong market presence are well recognized: in addition to her Band 1 ranking in Intellectual Property by Chambers & Partners, Eileen is the only Canadian lawyer to be recognized as a Star Individual in Life Sciences. Managing IP regards her as one of the world’s top 250 women in IP, and The Legal 500 recognizes her as one of Canada’s leading lawyers in intellectual property.
Eileen is a registered patent and trademark agent in the United States and Canada. She is also a Certified Licensing Professional of the Licensing Executive Society (LES).
Eileen is a former member of Torys’ Executive Committee.
Articles, highlights and press releases
3 items provided by Torys LLP
Emerging Companies in Canada: Data and Digital Technology and Life Sciences
The growth of Canada’s emerging company and tech sector has been on a path of acceleration. We are also seeing increased foreign investment into the industry, particularly from America. The tech sector’s presence is being felt nationwide. Here we discuss key growth areas to watch moving forwards.
Rewiring the supply chain: how the pandemic is shaping government procurement
COVID-19 has long-term implications for how governments think about procurement. Obtaining vaccines & critical supplies was no easy feat during the pandemic. This article examines domestic production, foreign procurement and how the global supply chain is shaping public policy goals and objectives.
Torys Business Brief: A turning point for Canada’s life sciences
What lessons can be learned from the pandemic for the life sciences industry? Hear from Eileen McMahon and Cheryl Reicin and researcher Dr. Shaf Keshavjee
Emerging Companies in Canada: Data and Digital Technology and Life Sciences
The growth of Canada’s emerging company and tech sector has been on a path of acceleration. We are also seeing increased foreign investment into the industry, particularly from America. The tech sector’s presence is being felt nationwide. Here we discuss key growth areas to watch moving forwards.
Rewiring the supply chain: how the pandemic is shaping government procurement
COVID-19 has long-term implications for how governments think about procurement. Obtaining vaccines & critical supplies was no easy feat during the pandemic. This article examines domestic production, foreign procurement and how the global supply chain is shaping public policy goals and objectives.
Torys Business Brief: A turning point for Canada’s life sciences
What lessons can be learned from the pandemic for the life sciences industry? Hear from Eileen McMahon and Cheryl Reicin and researcher Dr. Shaf Keshavjee
Discover other Lawyers at
Torys LLP
Alberta
Nationwide - Canada
